Show simple item record

dc.contributor.authorAwor, Silvia
dc.contributor.authorAbola, Benard
dc.contributor.authorByanyima, Rosemary
dc.contributor.authorGarimo Orach, Christopher
dc.contributor.authorKiondo, Paul
dc.contributor.authorKaye Kabonge, Dan
dc.contributor.authorOgwal-Okeng, Jasper
dc.contributor.authorNakimuli, Annettee
dc.date.accessioned2023-03-14T10:00:31Z
dc.date.available2023-03-14T10:00:31Z
dc.date.issued2023-02-08
dc.identifier.citationAwor, S., Abola, B., Byanyima, R. et al. Prediction of pre-eclampsia at St. Mary's hospital lacor, a low-resource setting in northern Uganda, a prospective cohort study. BMC Pregnancy Childbirth 23, 101 (2023). https://doi.org/10.1186/s12884-023-05420-zen_US
dc.identifier.otherhttps://doi.org/10.1186/s12884-023-05420-z
dc.identifier.urihttp://hdl.handle.net/10570/11907
dc.descriptionResearch articleen_US
dc.description.abstractBackground Pre-eclampsia is the second leading cause of maternal death in Uganda. However, mothers report to the hospitals late due to health care challenges. Therefore, we developed and validated the prediction models for prenatal screening for pre-eclampsia. Methods This was a prospective cohort study at St. Mary's hospital lacor in Gulu city. We included 1,004 pregnant mothers screened at 16–24 weeks (using maternal history, physical examination, uterine artery Doppler indices, and blood tests), followed up, and delivered. We built models in RStudio. Because the incidence of pre-eclampsia was low (4.3%), we generated synthetic balanced data using the ROSE (Random Over and under Sampling Examples) package in RStudio by over-sampling pre-eclampsia and under-sampling non-preeclampsia. As a result, we got 383 (48.8%) and 399 (51.2%) for pre-eclampsia and non-preeclampsia, respectively. Finally, we evaluated the actual model performance against the ROSE-derived synthetic dataset using K-fold cross-validation in RStudio. Results Maternal history of pre-eclampsia (adjusted odds ratio (aOR) = 32.75, 95% confidence intervals (CI) 6.59—182.05, p = 0.000), serum alkaline phosphatase(ALP) < 98 IU/L (aOR = 7.14, 95% CI 1.76—24.45, p = 0.003), diastolic hypertension ≥ 90 mmHg (aOR = 4.90, 95% CI 1.15—18.01, p = 0.022), bilateral end diastolic notch (aOR = 4.54, 95% CI 1.65—12.20, p = 0.003) and body mass index of ≥ 26.56 kg/m2 (aOR = 3.86, 95% CI 1.25—14.15, p = 0.027) were independent risk factors for pre-eclampsia. Maternal age ≥ 35 years (aOR = 3.88, 95% CI 0.94—15.44, p = 0.056), nulliparity (aOR = 4.25, 95% CI 1.08—20.18, p = 0.051) and white blood cell count ≥ 11,000 (aOR = 8.43, 95% CI 0.92—70.62, p = 0.050) may be risk factors for pre-eclampsia, and lymphocyte count of 800 – 4000 cells/microliter (aOR = 0.29, 95% CI 0.08—1.22, p = 0.074) may be protective against pre-eclampsia. A combination of all the above variables predicted pre-eclampsia with 77.0% accuracy, 80.4% sensitivity, 73.6% specificity, and 84.9% area under the curve (AUC). Conclusion The predictors of pre-eclampsia were maternal age ≥ 35 years, nulliparity, maternal history of pre-eclampsia, body mass index, diastolic pressure, white blood cell count, lymphocyte count, serum ALP and end-diastolic notch of the uterine arteries. This prediction model can predict pre-eclampsia in prenatal clinics with 77% accuracy.en_US
dc.description.sponsorshipSIDAen_US
dc.language.isoenen_US
dc.publisherBioMed Central (BMC)en_US
dc.subjectRisk predictionen_US
dc.subjectUterine artery Doppler indicesen_US
dc.subjectMaternal historyen_US
dc.subjectBlood testsen_US
dc.subjectPre-eclampsiaen_US
dc.subjectUgandaen_US
dc.subjectAfricaen_US
dc.titlePrediction of pre-eclampsia at St. Mary's hospital lacor, a low-resource setting in northern Uganda, a prospective cohort studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record